Cargando…

Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ

The incidence rates of cervical adenocarcinoma have been increasing over the last two decades, contrary to those of squamous cell carcinoma. This trend is particularly evident among females aged <40 years and has occurred despite extensive cytology-based screening programs. The aim of the present...

Descripción completa

Detalles Bibliográficos
Autores principales:	ANDERSSON, SONIA, MINTS, MIRIAM, WILANDER, ERIK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742506/ https://www.ncbi.nlm.nih.gov/pubmed/23946807 http://dx.doi.org/10.3892/ol.2013.1350

Ejemplares similares

Uneven distribution of human papillomavirus 16 in cervical carcinoma in situ and squamous cell carcinoma in older females: A retrospective database study
por: ANDERSSON, SONIA, et al.
Publicado: (2014)

Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment
por: Andersson, Sonia, et al.
Publicado: (2021)

Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?
por: Andersson, Sonia, et al.
Publicado: (2018)

Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia
por: Östensson, Ellinor, et al.
Publicado: (2021)

High viral loads of human papillomavirus predict risk of invasive cervical carcinoma
por: Moberg, M, et al.
Publicado: (2005)

Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow-up
por: Belkić, Karen, et al.
Publicado: (2022)

Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix.
por: Gustafsson, L., et al.
Publicado: (1995)

Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge
por: Andersson, Sonia, et al.
Publicado: (2017)

Cytology and Human Papillomavirus Co-Test Results Preceding Incident High-Grade Cervical Intraepithelial Neoplasia
por: Park, Ina U., et al.
Publicado: (2015)

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas
por: Andersson, S, et al.
Publicado: (2001)

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
por: Andersson, S, et al.
Publicado: (2005)

Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education
por: Andersson, Sonia, et al.
Publicado: (2019)

Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
por: Zhang, Liran, et al.
Publicado: (2017)

Chlamydia Trachomatis Infection in High-Risk Human Papillomavirus Based on Cervical Cytology Specimen
por: Sangpichai, Soracha, et al.
Publicado: (2019)

The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study
por: McKee, Kimberly S., et al.
Publicado: (2020)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination
por: Teoh, Deanna, et al.
Publicado: (2022)

Usefulness of the human papillomavirus DNA chip test as a complementary method for cervical cytology
por: Lee, Rae-Young, et al.
Publicado: (2023)

The Application of Liquid-Based Cytological Detection for P16, Cytologic Evaluation and High-Risk Human Papillomavirus Testing in Cervical Cancer Screening: A Clinical Evaluation
por: Zhao, Fang, et al.
Publicado: (2022)

Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study
por: Cobo, Fernando, et al.
Publicado: (2009)

Cervical Cytology and Human Papillomavirus Testing in Adolescent Women: Implications in Management of a Positive HPV Test
por: Rosa, Marilin, et al.
Publicado: (2014)

Cytology, High-Risk Human Papillomavirus Testing and Serum CA19-9 in a Large Cohort of Patients with Invasive Cervical Adenocarcinomas: Correlation with a New Pathogenetic Classification
por: Shi, Haiyan, et al.
Publicado: (2022)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
por: Fröberg, M, et al.
Publicado: (2008)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
por: Thomsen, Louise T, et al.
Publicado: (2020)

Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer
por: Gyllensten, U, et al.
Publicado: (2011)

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
por: Sherlaw-Johnson, C, et al.
Publicado: (2004)

Genotype Distribution of Human Papillomaviruses in Japanese Women with Abnormal Cervical Cytology
por: Kondo, Kazunari, et al.
Publicado: (2012)

Association of abnormal cervical cytology with coinfection of human papillomavirus and Chlamydia trachomatis
por: Madaan, Nisha, et al.
Publicado: (2019)

Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
por: Hellman, K, et al.
Publicado: (2014)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
por: Kailash, U, et al.
Publicado: (2006)

Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark – the SHADE
por: Thorsteinsson, Kristina, et al.
Publicado: (2016)

Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes
por: Abbas, Mahmoud, et al.
Publicado: (2022)

High-risk Human Papillomavirus Testing for Triage of Women with Previous Cytological Abnormalities from the Vale do Ribeira Region
por: Lorente, Sandra, et al.
Publicado: (2020)

Performance of cytology and human papillomavirus testing in relation to the menstrual cycle
por: Sherman, M E, et al.
Publicado: (2006)

Association between human papillomavirus (HPV) DNA and micronuclei in normal cervical cytology
por: Cassel, Ana Paula Rebelo, et al.
Publicado: (2014)

Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions
por: Li, Kemin, et al.
Publicado: (2015)

Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.
por: Mitchell, H., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_lg3vv3dhr6qirqqssdg8rmthof